Navigation Links
Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia

insomnia with more than 90% of current insomnia drugs using this mechanism. Importantly, however, its close to ideal half life of 3 to 4 hours and its partial agonist activity gives EVT 201 a differentiated preclinical profile and mechanism of action.

The headline results of the first Phase II study with EVT 201 were very positive in terms of all aspects of the problems faced by insomniacs, i.e. sleep onset and sleep maintenance and yet the patients didn't feel any drug hang-over effects after waking in the morning. Furthermore, in two previous Phase I/II proof-of-principle studies in subjects with induced insomnia, EVT 201 significantly reduced Wake After Sleep Onset (WASO) while significantly increasing the Total Sleep Time (TST) and quality of sleep with no subjective residual effects. The studies were conducted in a sleep laboratory setting using the traffic noise model of insomnia in healthy male volunteers. In this setting an average of 52 decibels of recorded traffic noise is played throughout the night thereby provoking insomnia. This model has been used to evaluate several insomnia treatments currently in development and on the market. EVT 201 showed no tolerance/dependence liabilities in pre-clinical studies and no interaction with alcohol.

Joern Aldag

President & Chief Executive Office

T: +49-(0)40-560-81-242

F: +49-(0)40-560-81-333

Anne Hennecke

Senior Vice President

Investor Relations & Corporate Communications

T: +49-(0)40-560-81-286

F: +49-(0)40-560-81-333

Evotec AG (Headquarters)

Schnackenburgallee 114

22525 Hamburg, Germany

Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
(Date:10/8/2015)... ALS Association, in partnership with Prize4Life, is pleased to ... technology solutions for people living with ALS. ... sclerosis) is a progressive neurodegenerative disease that affects neurons ... Eventually, people with ALS lose the ability to initiate ... paralysis and death within two to five years of ...
(Date:10/8/2015)... ... 2015 , ... Talon Innovations, a provider of Precision Machined Products ... it is one of three finalists for the Minnesota Business magazine’s Manufacturing Award in ... Talon Innovations was recognized as a nominee for this competitive award. , The ...
(Date:10/7/2015)... Mass. , Oct. 7, 2015 ... announced the start of the Boston Scientific Connected ... encourage advancements in the use of remote patient monitoring ... engineers, designers and entrepreneurs can submit their ideas and ... site ( ). Cambridge, MA ...
(Date:10/7/2015)... Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of targeted antiviral ... offering of 5,000,000 shares of its common stock and ... Company,s common stock at a fixed combined price to ... and warrants will be issued separately.  The warrants will ...
Breaking Biology Technology:
... Suggests that Understanding the Fundamental Mechanism of Angiogenesis ... VEGF - AAmgen Launches Angiogenesis Website THOUSAND OAKS, ... AMGN ) today announced that results from several ... be presented at the 2009 American Association for ...
... automating their environmental monitoring processes using MODA-EM™ , ... ... -- The Parenteral Drug Association (PDA) is hosting their annual ... Red Rock Casino and Resort. During this event, MODA Technology ...
... April 16 Cord Blood America, Inc. (OTC Bulletin ... company ( ) focused ... to families nationwide and internationally, said today that revenues ... increased 8.7 percent, or $0.3 million, to $3.4 million ...
Cached Biology Technology:
(Date:9/26/2015)... -- Results of a TactioRPM pilot project in a ... Stanford Medicine X Conference. In a presentation titled ... Devices and Pharmacogenomics", Roger Simard , Pharmacist ... senior patients equipped with connected health devices and ... TactioRPM remote patient monitoring platform were empowered to ...
(Date:9/10/2015)... Sept. 10, 2015 Report Details ... quite delivered upon previous expectations of revenues, consumer adoption ... breakthrough year in which wearables begin to achieve that ... of the main reasons is the entrance of Apple ... the SmartWatches market, but the overall size of the ...
(Date:9/8/2015)... -- Affectiva, global leader in emotion-sensing and analytics, announces ... data solution, and version 2.0 of its emotion-sensing ... and patented science, these new offerings provide unique ... such as market research, gaming, media and entertainment, ... HR, automotive, robotics, healthcare and wearables. ...
Breaking Biology News(10 mins):
... a venture once thought to lie outside the reach ... Israel Deaconess Medical Center have captured and sequenced tiny ... rex. The protein fragments—seven in all—appear to most closely ... day chickens, lending support to a recent and still ...
... disease regardless of the stage at time of diagnosis. ... of ductal adenocarcinoma associated with cystic lesions that can ... 50 percent long-term survival rate. Why cystic ductal pancreatic ... mutations as the more common and deadly type of ...
... mesothelioma ?a form of cancer associated with asbestos exposure ?have ... two cancer drugs, a large multicenter study finds. , Mesothelioma, ... the lining of the lungs, heart and abdomen, is associated ... , In the study, patients receiving pemetrexed and cisplatin ?along ...
Cached Biology News:
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Adhesion Molecule Antibodies...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: